DUSP16: A Protein Regulating Pancreatic Beta Cells and Cancer Development

Target Name: DUSP16

NCBI ID: G80824

DUSP16

DUSP16: A Protein Regulating Pancreatic Beta Cells and Cancer Development

DUSP16 (MGC129702) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the DUSP gene family, which is known for its role in cell signaling and development.

One of the functions of DUSP16 is to regulate the growth and differentiation of pancreatic beta cells, which are responsible for producing insulin to regulate blood sugar levels. beta cells are a critical component of the pancreas, and any damage or dysfunction in these cells can lead to a range of insulin-related diseases, including type 1 diabetes.

In addition to its role in pancreatic beta cell function, DUSP16 has also been shown to play a key role in the development and progression of cancer. It has been found to be highly expressed in various types of cancer, including pancreatic, breast, and ovarian cancer.

Furthermore, DUSP16 has also been shown to be involved in the regulation of inflammation and immune responses. It has been found to be expressed in various immune cells, including dendritic cells, macrophages, and T cells. In addition, DUSP16 has been shown to play a key role in the regulation of immune cell function and the production of antibodies.

DUSP16 is also known as MGC129702 because it is a potential drug target for a company called Moderna Therapeutics. The company has developed a monoclonal antibody called DUSP-160, which is designed to block the function of DUSP16 and prevent it from regulating the growth and differentiation of pancreatic beta cells.

In addition to its potential use as a drug target, DUSP16 also has potential as a biomarker for certain diseases. For example, it has been shown to be a potential biomarker for pancreatic cancer, as it has been found to be expressed in the majority of pancreatic cancer samples. In addition, DUSP16 has also been shown to be a potential biomarker for breast and ovarian cancer, as it has been found to be expressed in the majority of breast and ovarian cancer samples.

Overall, DUSP16 is a protein that has important roles in various physiological processes in the body. Its function as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand its role in disease and its potential as a drug and biomarker.

Protein Name: Dual Specificity Phosphatase 16

Functions: Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2

The "DUSP16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets